Science Explorer Back to mapMap
Discussion
Researcher · Sun Pharma (United States) · United States

Stephen J. Rozzo

Stephen J. Rozzo publishes mostly in Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging, on topics such as Psoriasis: Treatment and Pathogenesis, T-cell and B-cell Immunology and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#2,295,702
of 7,710,434 ranked researchers
Rank in United States
#685,024
of 1,627,098
Works
98
Citations
2.7k
Citations per work
28.0
h-index
27
i10-index 46Top 18% in Immunology
Stephen J. Rozzo

What does Stephen J. Rozzo research?

Stephen J. Rozzo's work is mostly in Immunology and Microbiology (42%), Medicine (34%), Economics, Econometrics and Finance (6%).

Life Sciences: 42 works · 42.5% of their workImmunology and Microbiology: 42 works · 42.5% of their workImmunology: 42 works · 42.5% of their workHealth Sciences: 33 works · 33.9% of their workMedicine: 33 works · 33.9% of their workRheumatology: 16 works · 16.7% of their workRadiology, Nuclear Medicine and Imaging: 7 works · 7.3% of their workDermatology: 5 works · 5.5% of their workPathology and Forensic Medicine: 4 works · 4.4% of their workEverything else: 17 works · 17.8% of their workSocial Sciences: 6 works · 5.8% of their workEconomics, Econometrics and Finance: 6 works · 5.8% of their workEconomics and Econometrics: 6 works · 5.8% of their workTHEIR WORKStephen J. Rozzo98works
Life Sciences42%Health Sciences34%Social Sciences6%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology4242.5%
    1. Medicine3333.9%
  3. Everything else1717.8%
    1. Economics, Econometrics and Finance65.8%
  1. 1Immunology42% of their works
  2. 2Rheumatology17% of their works
  3. 3Radiology, Nuclear Medicine and Imaging7% of their works
  4. 4Economics and Econometrics6% of their works
  5. 5Dermatology6% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Stephen J. Rozzo's research?

The keywords of their largest research topics: TGF-ß, IL-17, TH17 Cells, CD4+CD25+, Foxp3, Fc Receptors, Therapeutic Antibodies and Ankylosing Spondylitis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. TGF-ß862 topics
  2. IL-17631 topic
  3. TH17 Cells631 topic
  4. CD4+CD25+231 topic
  5. Foxp3231 topic
  6. Fc Receptors201 topic
  7. Therapeutic Antibodies201 topic
  8. Ankylosing Spondylitis181 topic
  9. Antiphospholipid Syndrome181 topic
  10. Spondyloarthritis181 topic
  11. Systemic Lupus Erythematosus181 topic
  12. Cost-effectiveness Analysis161 topic
  13. Quality of Life161 topic
  14. Filaggrin131 topic
  15. Skin Microbiome131 topic
  16. Off-Label Drug Use121 topic
  17. Pediatric Pharmacokinetics121 topic

Where does Stephen J. Rozzo work?

Stephen J. Rozzo's main affiliation in the publication record is Sun Pharma (United States), United States.

How many publications and citations does Stephen J. Rozzo have?

OpenAlex counts 98 works and 2,747 citations for Stephen J. Rozzo, an h-index of 27, ranking #2,295,702 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Stephen J. Rozzo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.